95252 ⎘
Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a chain containing hetero atoms as chain links
Alpha-substituted -sulfonyl gylcine amides antagonists of CCR10, compositions containing the same and methods for using them
#5402Nuclear transport modulators and uses thereof
#5403Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders
#5404Tetrazolones as inhibitors of fatty acid synthase
#5405Oxoazetidine derivatives, process for the preparation thereof and use thereon in human medicine and in cosmetics
#5406Pyrazole compounds for controlling invertebrate pests
#5407Urotensin II receptor antagonists
#5408Benzimidazole-4-carboxamide derivatives, their preparation methods, pharmaceutical compositions and their uses
#54092-phenyl pyrazines as tubulin inhibitors
#5410PYRIMIDINE COMPOUNDS AS DELTA OPIOID RECEPTOR MODULATORS
#54116-arylalkylamino-2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HTreceptor agonists
#5412DRUG DISCOVERY METHODS
#5413Inhibitors of IAP
#5414LIGAND-DIRECTED COVALENT MODIFICATION OF PROTEIN
#5415METHODS FOR TREATING HEPATITIS C
#5416Novel compounds
#5417SUBSTITUTED PYRIDINES AND PYRIDAZINES WITH ANGIOGENESIS INHIBITING ACTIVITY
#54183-aminoalkyl-1,4-diazepan-2-one melanocortin-5-receptor antagonists
#5419Compounds
#5420Indazole compounds useful as ketohexokinase inhibitors
#5421Azetidines as MEK inhibitors for the treatment of proliferative diseases
#5422Pyridone and pyridazone analogues as GPR119 modulators
#5423Inhibitors of Cancer Cell, T-Cell and Keratinocyte Proliferation
#5424Process for the manufacture of 4-fluoro-2-methyl-1H-indol-5-ol
#5425Small-Molecule Choline Kinase Inhibitors as Anti-Cancer Therapeutics
#5426Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
#5427Dipeptidyl peptidase IV inhibitors
#5428Compounds and compositions as protein kinase inhibitors
#5429Compounds and compositions as protein kinase inhibitors
#5430Apoptosis promoters
#5431Triazole compounds as KSP inhibitors
#5432PIPERAZINE DERIVATIVES
#5433Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
#54342,4-DIAMINO-PYRIMIDINES AS AURORA INHIBITORS
#5435HETEROCYCLIC COMPOUNDS AND METHODS OF USE
#5436Quinoxaline derivative, and light-emitting element, light-emitting device, electronic device using the quinoxaline derivative
#5437Triazole-substituted arylamides as P2X3 and P2X2/3 antagonists
#5438Heterocyclic compounds and their uses
#5439Small molecule potentiators of metabotropic glutamate receptors
#5440Heterocyclically Substituted Anilinopyrimides
#5441Small molecule potentiators of metabotropic glutamate receptors I
#5442ACTIVE SUBSTANCE AND PHARMACEUTICAL COMPOSITION FOR TREATING ALCOHOL DEPENDENCE, AND A METHOD FOR OBTAINING AND THE USE OF SAID ACTIVE SUBSTANCE
#5443Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
#5444Quinazolinamide derivatives
#5445Compounds and compositions as modulators of GPR119 activity
#5446Treatment of amyotrophic lateral sclerosis
#5447Spiro Compounds And Methods Of Use
#5448Hydrazonopyrazole derivatives and their use as therapeutics
#5449Cyclopentyl- and cycloheptylpyrazoles
#5450Pyrimidines
#5451Heteroaryl-substituted urea modulators of fatty acid amide hydrolase
#54521,3,5-triazine-2,4,6-triamine compound or pharmaceutical acceptable salt thereof, and pharmaceutical composition comprising the same
#5453Substituted propenyl piperazine derivatives as novel inhibitors of histone deacetylase
#5454Kynurenine production inhibitor
#54552-aminopyrimidin-4-one and 2-aminopyridine derivatives both having BACE1-inhibiting activity
#5456N-(hetero)aryl, 2-(hetero)aryl—substituted acetamides for use as Wnt signaling modulators
#5457Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives
#5458Phthalazine derivatives as inhibitors of protein kinase
#5459Substituted 2-(5-hydroxy-2-methyl-1H-indole-3-yl)acetic acids and ethers thereof and the use of same to treat viral diseases
#5460Quinazoline inhibitors of BACE 1 and methods of using
#5461Inhibitors of phosphoinositide dependent kinase 1 (PDK1)
#54624,6-disubstituted pyrimidines useful as kinase inhibitors
#5463s-Triazine compounds, pharmaceutical compositions and methods of using the same
#54646-PHENYL-PYRIMIDIN-4-YL-(PHENYLAMINE OR PHENOXY) DERIVATIVES USEFUL AS MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS
#5465Pyridine and pyrazine derivative for the treatment of CF
#5466DERIVATIVES OF TETRABROMOBENZIMIDAZOLE, A PROCESS FOR THE PREPARATION THEREOF, A PHARMACEUTICAL COMPOSITION COMPRISING THE SAME, A METHOD OF USING THE SAME, A METHOD FOR MODULATING OR REGULATING SERINE/THREONINE KINASES, AND SERINE/THREONINE KINASES MODULATING AGENT
#5467VIRAL POLYMERASE INHIBITORS
#54682H-chromene compound and derivative thereof
#5469Phenyl-heteroaryl derivatives and methods of use thereof
#5470Substituted imidazoles useful for treating type II diabetes
#54714,6-disubstitued pyrimidines useful as kinase inhibitors
#5472Tripeptidyl peptidase inhibitors
#5473Bicyclic dihydroimidazolone CGRP receptor antagonists
#5474NOVEL BIS-AMIDES AS ANTI-MALARIAL AGENTS
#5475Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases
#5476Heterocyclic aspartyl protease inhibitors
#5477Fluoroalkyl-substituted 2-amidobenzimidazoles
#5478Quinazolinone Compounds and Methods of Use Thereof
#5479Substituted hydroxamic acids and uses thereof
#5480Small Molecule Choline Kinase Inhibitors, Screening Assays, and Methods for Safe and Effective Treatment of Neoplastic Disorders
#5481PHENETHYLAMIDE DERIVATIVES AND THEIR HETEROCYCLIC ANALOGUES
#5482p38 MAP kinase inhibitors
#5483Compounds for the reduction of β-amyloid production
#5484Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
#5485N-Substituted Benzene Sulfonamides
#5486Bi-aryl meta-pyrimidine inhibitors of kinases
#5487THROMBOPOIETIN MIMETICS
#5488Substituted bicyclic amines for the treatment of diabetes
#5489COMPOUNDS THAT MODULATE EGFR ACTIVITY AND METHODS FOR TREATING OR PREVENTING CONDITIONS THEREWITH
#5490Quinolin-4-one and 4-oxodihydrocinnoline derivatives as inhibitors of poly(ADP-ribose) polymerase (PARP)
#5491Anthra [1, 2-d]imidazole-6,11-dione derivatives, preparation method and application thereof
#5492Serotonin receptor modulators
#5493Phosphatidylinositol 3-kinase inhibitors and methods of their use
#5494Methods for treating atherosclerosis
#5495AMIDE SUBSTITUTED INDAZOLE AND BENZOTRIAZOLE DERIVATIVES AS POLY(ADP-RIBOSE)POLYMERASE (PARP) INHIBITORS
#5496Pyrazine derivatives as ENAC blockers
#5497Sulfonamide compounds or salts thereof
#5498Therapeutic oxy-phenyl-aryl compounds and their use
#5499Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof
#5500Cosmetic composition, compound and cosmetic treatment method
#5501Substituted arylpyrazoles
#5502Inhibitors of c-fms kinase
#5503Isatin derivatives for use as in vivo imaging agents
#5504Heterocyclic indazole derivatives
#55052,4-pyrimidinediamine compounds and uses as anti-proliferative agents
#5506Benzimidazole linked pyrrolo[2,1-c[1,4] benzodiazepine hybrids as potential antitumour agents and process for the preparation thereof
#5507Compounds and compositions as protein kinase inhibitors
#5508Bicyclic heterocycles as MEK kinase inhibitors
#5509Cyclohexyloxy substituted heterocycles, pharmaceutical compositions containing these compounds and processes for preparing them
#5510Cosmetic composition, cosmetic treatment method, and compound
#5511Insecticidal Benzenedicarboxamide Derivative
#5512Stereoselective synthesis of bicyclic heterocycles
#5513Benzene, pyridine, and pyridazine derivatives
#5514Aromatic ring fused triazine derivatives and uses thereof
#5515AZETIDINE POLYSUBSTITUTED COMPOUNDS, PREPARATION THEREOF, AND THERAPEUTIC APPLICATION THEREOF
#5516Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
#5517TRICYCLIC 2,4-DIAMINO-L,3,5-TRIAZINE DERIVATIVES USEFUL FOR THE TREATMENT OF CANCER AND MYELOPROLIFERATIVE DISORDERS
#5518Complexes Comprising alpha2-Adrenergic Receptor Agonists and Methods of Providing Neuroprotection or Treating or Inhibiting Progression of Glaucoma
#5519ORGANIC COMPOUNDS AND THEIR USES
#5520NOVEL CARBOXYLIC ACID DERIVATIVES, THEIR PREPARATION AND USE
#5521Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
#5522Anti-Heparin Compounds
#5523HIV-1 Protease Inhibitors
#5524Adamantyl diamide derivatives and uses of same
#5525Inhibitors of interleukin-1β converting enzyme
#5526Spiro-imidazolone derivatives as glucagon receptor antagonists
#5527METHODS FOR THE PREPARATION OF INDAZOLE-3-CARBOXYLIC ACID AND N-(S)-1-AZABICYCLO[2.2.2]OCT-3-YL-1H-INDAZOLE-3-CARBOXAMIDE HYDROCHLORIDE SALT
#55282,4-diaminopyrimidine derivatives
#5529AMINE-BASED COMPOUND AND USE THEREOF
#5530COMPOUNDS AND THEIR USE
#5531Modified carbocyanine dyes and their conjugates
#5532INHIBITORS OF SERINE PROTEASES
#5533Method for producing optically active amino acid derivative
#55347-membered ring compound and method of production and pharmaceutical application thereof
#5535Substituted Isoindolones and Their Use as Metabotropic Glutamate Receptor Potentiators
#5536NOVEL SULPHONYLPYRROLES
#5537Substituted naphthalenyl-pyrimidine compounds
#5538AROMATIC NITROGEN-CONTAINING 6-MEMBERED RING COMPOUNDS AND THEIR USE
#5539Sulfonyl amide derivatives for the treatment of abnormal cell growth
#5540Imidazole and Triazole Compounds, Use Thereof and Agents Containing Said Compounds
#55415-ARYL-4,5-DIHYDRO-(1H)-PYRAZOLINES AS CANNABINOID CB1 RECEPTOR AGONISTS
#5542COMPOSITIONS AND METHODS OF USE FOR TREATING OR PREVENTING LIPID RELATED DISORDERS
#5543Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
#5544Substituted pyridazine carboxamide compounds as kinase inhibitor compounds
#5545Pyrazine compounds as phosphodiesterase 10 inhibitors
#55463-aryl-5,6-disubstituted pyridazines
#5547Pyrazine compounds as phosphodiesterase 10 inhibitors
#5548Substituted pyrazoline compounds, their preparation and use as medicaments
#5549Heterosubstituted N-thiolated beta-lactam compounds and methods of use
#5550Compositions comprising N3 alkylated benzimidazole derivatives as MEK inhibitors and methods of use thereof
#5551Cycloalkyl substituted pyrimidinediamine compounds and their uses
#5552Compounds and compositions as hedgehog pathway inhibitors
#5553Compounds and method for treatment of cancer
#5554Indazole derivatives as modulators of interleukin-1 receptor-associated kinase
#5555Tetrahydroquinolinyl compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor and uses thereof
#5556Substituted benzamides
#5557Chemical compounds
#5558AZETIDINE POLYSUBSTITUTED COMPOUNDS, PREPARATION THEREOF, AND THERAPEUTIC APPLICATION THEREOF
#5559CRTH2 modulators
#5560Inhibition of bacterial biofilms with imidazole derivatives
#55612,4-pyrimidinediamine compounds and their uses
#5562Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
#5563Substituted heterocyclic mercaptosulfonamide metalloprotease inhibitors
#55641-heterocyclylsulfonyl, 3-aminomethyl, 5-(hetero-)aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors
#5565Amide compound
#5566Bridged bicyclic RHO kinase inhibitor compounds, composition and use
#55675-(5-(2-(3-aminopropoxy)-6-methoxyphenyl)-1H-pyrazol-3-ylamino)pyrazine-2-carbonitrile, pharmaceutically acceptable salts thereof, or solvate of salts
#5568Apoptosis promoters
#5569Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
#5570Cyclopropane indolinone derivatives
#5571Pyrazole derivatives as protein kinase modulators
#5572Small molecule inhibitors of the pleckstrin homology domain and methods for using same
#5573PYRAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH
#5574Analysis of Amino Acids And Amine-Containing Compounds Using Tagging Reagents and LC-MS Workflow
#5575Highly water-soluble, cationic luminescent labels
#5576Azo compound, azo pigment, pigment dispersion, coloring composition, ink for inkjet recording, coloring composition for color filter, color filter, and process for preparing a coloring composition for color filter
#5577Compound containing basic group and use thereof
#5578Compounds
#5579Compounds
#5580Urotensin II receptor antagonists
#5581Diazepine and diazocane compounds as MC4 agonists
#5582Bicyclic compositions and methods for modulating a kinase cascade
#5583Bicyclic heterocycles, pharmaceutical compositions containing these compounds, the use thereof and processes for the preparation thereof
#5584IDO inhibitors
#5585AURORA KINASE INHIBITORS
#5586Amino pyrimidine anticancer compounds
#5587Compounds and compositions as protein kinase inhibitors
#5588Antiviral compounds
#5589Heterocyclic Carboxamides For Use As Thrombin Inhibitors
#5590Compounds which modulate the CB2 receptor
#5591Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders
#5592Fluorinated Heteroaryls
#5593Composition and process for whitening paper
#5594Modulators of cellular adhesion
#5595Indole derivative having, carbamoyl group, ureido group and substituted oxy group
#5596Benzimidazoles and related analogs as sirtuin modulators
#5597BENZAZEPINE DERIVATIVES AND THEIR USE AS HISTAMINE H3 ANTAGONISTS
#5598Modulators of cellular adhesion
#5599High performance luminescent compounds
#5600CARBAMOYLBENZOTRIAZOLE DERIVATIVES AS INHIBITORS OF LIPASES AND PHOSPHOLIPASES
#5601Indol-2-one derivatives disubstituted in the 3-position, preparation thereof and therapeutic use thereof
#5602Substituted amide derivatives and methods of use
#5603HETEROCYCLIC COMPOUND
#5604FUNCTIONALIZED PYRROLIDINES AND USE THEREOF AS IAP INHIBITORS
#5605Protein kinase conjugates and inhibitors
#5606BENZISOXAZOLE ANALOGS AS GLYCOGEN SYNTHASE ACTIVATORS
#5607Heterocyclic sulfonamides
#5608Pyrimidine derivatives as kinase inhibitors
#56091-aryl-3-aminoalkoxy pyrazoles as sigma ligands enhancing analgesic effect of opioids and attenuating the dependency thereof
#5610DERIVATIVES OF TETRABROMOBENZIMIDAZOLE, A PROCESS FOR THE PREPARATION THEREOF, A PHARMACEUTICAL COMPOSITION COMPRISING THE SAME, A METHOF OF USING THE SAME, A METHOD FOR MODULATING OR REGULATING SERINE/THREONINE KINASES, AND SERINE/THREONINE KINASES MODULATING AGENT
#5611Pyrazoles for the treatment of obesity and other CNS disorders
#5612Oxazoline derivatives
#5613Pyrimidine derivatives as kinase inhibitors
#5614Carbamate and urea inhibitors of 11Beta-hydroxysteroid dehydrogenase 1
#5615Derivatives of 6[3-(trifluoromethyl)phenyl]pyridazin-3(2H)-one having antitumor activity
#56161,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
#5617Modulators of calcium release-activated calcium channel and methods for treatment of non-small cell lung cancer
#5618Dipeptidyl peptidase-IV inhibitors
#5619COMPOSITION, AND LIGHT-EMISSION ELEMENT PRODUCED BY USING THE COMPOSITION
#5620PHOSPHORESCENT LIGHT-EMITTING COMPOSITION AND LIGHT-EMITTING ELEMENT COMPRISING THE COMPOSITION
#5621Modulation of pathogenicity
#5622CARBAMIC ACID COMPOUNDS COMPRISING AN AMIDE LINKAGE AS HDAC INHIBITORS
#5623Method for the production of sulphonylpyrroles as HDAC inhibitors
#5624Selective subtype alpha 2 adrenergic agents and methods for use thereof
#5625Pyrimidine compounds as delta opioid receptor modulators
#5626Quinoxaline and quinoline derivatives as kinase inhibitors
#5627Diaminopyrimidines as crop protection agents
#5628Triazole derivative or salt thereof
#56293-PHENYL-PYRAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
#5630Phenoxy-substituted pyrimidines as opioid receptor modulators
#5631Modulators of calcium release-activated calcium channel
#5632Hexahydrocyclopentyl[f]indazole sulfonamides and derivatives thereof as selective glucocorticoid receptor modulators
#5633Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
#5634Amino substituted pyrazines as inhibitors or protein kinases
#5635Spirolactam derivatives and uses of same
#5636SULFONAMIDES AS ZAP-70 INHIBITORS
#56372,4-PYRIMIDINEDIAMINES USEFUL IN THE TREATMENT OF NEOPLASTIC DISEASES, INFLAMMATORY AND IMMUNE SYSTEM DISORDERS
#5638Fab I inhibitors
#5639Substituted Pyridazinone Derivatives as Histamine-3 (H3) Receptor Ligands
#5640Substituted Dihydroquinazolines as Platelet ADP Receptor Inhibitors
#5641Fluorescent whitening agent compositions
#5642Adamantyl Iminocarbonyl-Substituted Pyrimidines As Inhibitors Of 11-Beta-HSD1 826
#5643HSL inhibitors useful in the treatment of diabetes
#5644Trisubstituted amine compound
#5645Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
#5646(E)-N-(2-amino-phenyl)-3-{1-[4-(l-methyl-1H-pyrazol-4-yl)-benzenesulfonyl]-1H-pyrrol-3-yl}-acrylamide salts
#5647TETRAZOLE COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS
#5648COMPOSITIONS USEFUL AS INHIBITORS OF PROTEIN KINASES
#5649N-substituted-pyrrolidines as inhibitors of MDM2-P-53 interactions
#5650Therapeutic Compounds
#5651Pyrimidines as PLK inhibitors
#5652CHEMICAL COMPOUNDS
#5653Polymerizable liquid crystal compound and its polymer
#5654Uracil compound or salt thereof having human deoxyuridine triphosphatase inhibitory activity
#5655Gamma secretase modulators
#5656SULFONYLUREA MODULATORS OF ENDOTHELIN RECEPTOR
#5657N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes
#56581,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
#5659Triazole derivatives useful as Axl inhibitors
#5660Substituted Azole Derivatives as Therapeutic Agents
#5661Heterocyclic compounds and thrombopoietin receptor activators
#5662Benzimidazole derivatives
#56631,2,4-triazolylaminoaryl (heteroaryl) sulfonamide derivatives
#5664Bicyclic heterocyclic compounds pharmaceutical compositions containing these compounds, their use and process for preparing the same
#5665Substituted 2-alkyl quinazolinone derivatives as PARP inhibitors
#5666Diaminopyrimidines as P2Xand P2Xantagonists
#5667Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them
#5668Carboxylic acid amides, the preparation thereof and their use as medicaments
#5669C-Met Modulators and Method of Use
#5670AMINOPYRAZOLE AMIDE DERIVATIVE
#5671Modulators of ATP-binding cassette transporters
#5672Chemical compounds 572
#5673Indoles and their therapeutic use
#5674NEW COMPOUNDS
#5675Substituted benzothiazoles as orexin antagonists
#56765-membered heterocycle-based p38 kinase inhibitors
#5677Selective kinase inhibitors
#567817BetaHSD Type 5 Inhibitor
#5679QUINAZOLINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
#5680SUBSTITUTED PHENYLAMINO-BENZENE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH MITOGEN EXTRACELLULAR KINASE ACTIVITY
#5681Deuterated hepatitis C protease inhibitors
#5682Non-steroidal androgens compounds
#5683NOVEL BIFUNCTIONAL COMPOUNDS WHICH INHIBIT PROTEIN KINASES AND HISTONE DEACETYLASES
#5684TRIAZOLE AMIDE DERIVATIVES FOR USE IN THERAPY
#5685Benzazole derivatives, compositions, and methods of use as β-secretase inhibitors
#5686Therapeutic Agents 812
#5687Compounds for modulating RNA binding proteins and uses therefor
#5688Indazolyl, benzimidazolyl, benzotriazolyl substituted indolinone derivatives as kinase inhibitors useful in the treatment of cancer
#5689Phthalazine derivatives as PARP inhibitors
#5690Amide compounds, compositions and uses thereof
#5691Phenylpyrazole derivatives
#5692Phenylpyrazole derivatives
#5693IRE-1α inhibitors
#5694Polycyclic Organic Compounds, Retardation Layer and Compensation Panel on Their Base
#5695Hepatitis C virus inhibitors
#5696Hepatitis C virus inhibitors
#5697Regioselective preparation of substituted pyrimidines
#5698Modulators of ATP-binding cassette transporters
#56993,5-diamino-6-chloro-pyrazine-2-carboxylic acid derivatives and their use as epithelial sodium channel blockers for the treatment of airway diseases
#5700Co-crystals and pharmaceutical compositions comprising the same